Search Within

Christopher G Azzoli

  1. "Leslie Tyson"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (13)
  2. Nursing (13)
  3. Solid Tumor Oncology Division (13)
  4. Thoracic Oncology (13)
  5. Advanced Practice Providers (10)
  6. Survivorship Research (10)

More Groups

People
  1. Leslie Tyson (13)
  2. Mark Kris (13)
  3. Vincent Miller (11)
  4. Lee Krug (10)
  5. Barbara Pizzo (9)
  6. Megan Dunne (9)

More People

Years
  1. 2013 (1)
  2. 2011 (1)
  3. 2007 (4)
  4. 2005 (3)
  5. 2004 (2)
  6. 2003 (2)
Publications
  1. Clinical Cancer Research (3)
  2. Journal of Clinical Oncology (3)
  3. Journal of Thoracic Oncology (3)
  4. Cancer (2)
  5. Lung Cancer (1)
  6. Molecular Cancer Therapeutics (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (3)
  4. Wiley Blackwell (2)
  5. Elsevier Ireland Ltd. (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers
    Meeting Abstract

    Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase I study of the antifolate pralatrexate given with vitamin B(12) and folic acid supplementation in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Krug, L.; Miller, V.; Bekele, S.; Tyson, L.; Dunne, M.; Huntington, M.; Saunders, M.; Kris, M. G.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    James, L. P.; Azzoli, C. G.; Krug, L. M.; Miller, V.; Tripathi, P.; Subzwari, S.; Tyson, L. B.; Dunne, M.; Huntington, M. F.; Saunders, M. E.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Rizvi, N. A.; Kris, M. G.; Dunne, M.; Farmer, A.; Pizzo, B.; Tyson, L.; Seeger, T.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX, pralatrexate) plus docetaxel in patients with advanced Non-Small Cell Lung Cancer (NSCLC)
    Meeting Abstract

    Gomez, J.; Azzoli, C.; Krug, L.; Ginsberg, M.; Henry, R.; Tyson, L.; Pizzo, B.; Dunne, M.; Kris, M.; Sirotnak, F.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma
    Journal Article

    Krug, L. M.; Miller, V. A.; Patel, J.; Crapanzano, J.; Azzoli, C. G.; Gomez, J.; Kris, M. G.; Heelan, R. T.; Pizzo, B.; Tyson, L.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: A phase II clinical trial
    Journal Article

    Krug, L. M.; Crapanzano, J. P.; Azzoli, C. G.; Miller, V. A.; Rizvi, N.; Gomez, J.; Kris, M. G.; Pizzo, B.; Tyson, L.; Dunne, M.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial
    Meeting Abstract

    Krug, L. M.; Crapanzano, J. P.; Miller, V. A.; Azzoli, C. G.; Rizvi, N.; Gomez, J.; Pizzo, B.; Tyson, L.; Dunne, M.; Kris, M. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save